Loading...
Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Apr. 10, 2025 Chinese

Table of Content

    Volume 30 Issue 4
    26 April 2025
    Expert consensus on the model informed precision dosing of tacrolimus in patients receiving anti-rejection therapy
    CHEN Bing, ZUO Xiaocong, LI Xingang, SHANG Dewei, ZHOU Peijun, DING Junjie, XIANG Xiaoqiang, QIU Xiaoyan, WANG Zhuo, LI Xiaoyu, ZHANG Yi, ZHAO Wei, WANG Yuzhu, GAO Jianjun, JIAO Zheng
    2025, 30(4):  433-445.  doi:10.12092/j.issn.1009-2501.2025.04.001
    Asbtract ( 9 )   PDF (844KB) ( 0 )  
    Related Articles | Metrics
    There is significant inter-individual variation of pharmacokinetics and pharmacodynamics in patients receiving tacrolimus (TAC) for anti-rejection therapy, which cause the rejection or toxic action. Based on results of therapeutic drug monitoring and pathophysiological index of transplant patients, the individualized dosing regimen can be designed and adjusted by using model informed precision dosing (MIPD). The patients' clinical outcome can be improved. In the consensus, the different methods of MIPD used for patients received TAC for anti-rejection therapy were introduced, which can be used for the designing and adjusting doing regimen, predicting adverse drug reaction, improving medication adherence and economics during therapy.
    Association of white blood cell count with venous thromboembolism: a two-way Mendelian randomization study
    GUO Zhanli, WANG Yuan, ZHANG Lei, LI Jiayuan, LI Ruoning, DONG Ying, SUN Jianjun
    2025, 30(4):  446-455.  doi:10.12092/j.issn.1009-2501.2025.04.002
    Asbtract ( 9 )   PDF (3099KB) ( 1 )  
    Related Articles | Metrics
    AIM: To explore the causal association between the counts of five types of white blood cells—neutrophils, monocytes, eosinophils, basophils, and lymphocytes—and venous thromboembolism (VTE). METHODS: Mendelian randomization (MR) analysis method was used, with genetic variants associated with the five types of white blood cells as instrumental variables, and venous thromboembolism occurrence risk as the outcome variable, inverse variance-weighted (IVW) method was employed as the primary analysis method, with MR-Egger regression, weighted median (WM), simple model, and weighted mode methods used as supplements, to analyze the causal association between the counts of five types of white blood cells and VTE, followed by reverse MR analysis. RESULTS: Neutrophil and lymphocyte counts are causally associated with the risk of VTE. For neutrophil count, the IVW estimate (OR=0.867, 95%CI: 0.761-0.981, P=0.031), MR-Egger estimate (OR=0.754, 95%CI: 0.571-0.996, P=0.048), weighted median estimate (OR=0.846, 95%CI: 0.729-0.981, P=0.027), and weighted model estimate (OR=0.748, 95%CI: 0.595-0.942, P=0.014) were calculated. For lymphocyte count, the IVW estimate (OR=0.838, 95%CI: 0.741-0.949, P=0.005) and weighted median estimate (OR=0.024, 95%CI: 0.718-0.977, P=0.024) were calculated. Reverse MR analysis showed a causal association between the risk of VTE and neutrophil count, the IVW estimate (OR=0.989, 95%CI: 0.980-0.999, P=0.024). CONCLUSION: Neutrophil and lymphocyte counts are related to the risk of VTE, and decrease in neutrophil and lymphocyte numbers may increase the risk of VTE. VTE occurrence risk is associated with neutrophil count, and reducing the risk of VTE occurrence may increase neutrophil count. Further research is needed to understand the underlying biological mechanisms behind this relationship.
    Qingre sanzhuo decoction treats hyperuricemia complicated with gouty arthritis via TLR4/Myd88/NF-κB signaling pathway
    CHENG Weigang, LI Haolin, YANG Juanjuan, BAI Qian, JING Luoyang, HU Lele, JIN Fangmei, WANG Haidong
    2025, 30(4):  456-463.  doi:10.12092/j.issn.1009-2501.2025.04.003
    Asbtract ( 12 )   PDF (1841KB) ( 1 )  
    Related Articles | Metrics
    AIM: To investigate the therapeutic effect of Qingre sanzhuo decoction on rats with hyperuricaemia combined with gouty arthritis and its effect on TLR4/Myd88/NF-κB signalling pathway. METHODS: Forty-eight SD male rats were randomly divided into blank, model, and colchicine groups (0.3 mg·kg-1·d-1), and Origre sanzhou decotion low, medium and highdosage groups (7.42, 14.85, 29.70 g·kg-1·d-1), which were treated with the modified Coderre method for hyperuricemia combined with acute gouty arthritis via gavage of yeast paste combined with potassium oxalate, which was used for the treatment of acute gouty arthritis combined with hyperuricemia. A composite rat model of acute gouty arthritis was constructed by combining yeast paste with potassium oxalate gavage to cause hyperuricaemia, combined with the modified Coderre method. After 7 days of intervention, the circumference of the right ankle joint of rats was measured and the swelling of the ankle joint was calculated, the blood uric acid (HUA) level of rats was determined by biochemical method, the histopathological and morphological changes of the synovial membrane of the ankle joint of rats were examined by HE staining, and the serum levels of inflammatory factors, tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and IL-1β were determined by enzyme-linked immunosorbent assay (ELISA), and Western blotting was performed to determine the levels of inflammatory factors, TNF-α, and IL-1β. The protein expression levels of Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (Myd88), and nuclear factor-κB (NF-κB) in the synovial tissues of the ankle joints of the rats were determined by Western blot method, and the mRNA expression of TLR4, Myd88, and NF-κB in the rat was determined by real-time fluorescence quantitative polymerase chain reaction (Real-time PCR). RESULTS: Compared with the blank group, rats in the model group showed significantly lower ankle joint swelling (P<0.01), increased levels of HUA, disorganised synovial tissue structure, large number of inflammatory cells infiltration, and significantly higher serum levels of TNF-α, IL-6, and IL-1β (P<0.01), and the protein and mRNA expression levels of TLR4, Myd88, and NF-κB in the synovial membrane of the ankle joints of the model group were significantly increased (P<0.01). levels were significantly increased (P<0.01); compared with the model group, joint swelling was significantly reduced in the colchicine group, and the medium- and high-dose groups of Qingre sanzhuo decoction (P<0.05); synovial hyperplasia and inflammatory cell infiltration were improved in the colchicine group and the medium- and high-dose groups of Qingre sanzhuo decoction, and the HUA and the levels of TNF-α, IL-6, and IL-1β were significantly decreased in the dosing groups (P<0.05, P<0.01), and compared with the model group, the medium- and high-dose groups of Qingre sanzhuo decoction could significantly reduce the expression of TLR4, Myd88, and NF-κB protein and mRNA (P<0.01). CONCLUSION: Qingre sanzhuo decoction reduces the release of inflammatory factors by inhibiting the TLR4/Myd88/NF-κB pathway, and plays a role in the treatment of hyperuricaemia combined with gouty arthritis.
    Exploring the mechanism of action of BLJZF in the treatment of lipid abnormalities
    LIU Gen, YANG Weidong, LI Jia, LIU Cong, HAO Xuliang
    2025, 30(4):  464-476.  doi:10.12092/j.issn.1009-2501.2025.04.004
    Asbtract ( 8 )   PDF (3798KB) ( 0 )  
    Related Articles | Metrics
    AIM:To explore the mechanism of BLJZF in the treatment of abnormal lipid metabolism based on network pharmacology, molecular docking and in vivo animal experiments. METHODS:TCMSP database, Swiss Target Prediction database, STITCH database and literature search were used to collect and query the chemical composition information of BLJZF and the corresponding target of drug chemical composition. Disease targets of lipid abnormalities were collected through GeneCards and OMIM databases. Metascape database was used to analyze the gene ontology function and the Kyoto Encyclopedia gene and genome pathway enrichment of common intersection targets. Cytoscape software was used to construct the correlation network diagram of components and targets, so as to select major components and targets for molecular docking study. The hyperlipidemia model was induced by high fat diet, and the control group, model group, positive group and BLJZF group were set up. The serum lipid index contents of triglyceride (TG), total cholesterol (TC), low lipoprotein cholesterol (LDL-C) and high lipoprotein cholesterol (HDL-C) were detected after continuous administration for 4 weeks. The contents of oxidative stress index were detected: alanine aminotransferase (ALT) and aspartate aminotransferase (AST). The contents of superoxide dismutase (SOD) and malondialdehyde (MDA) were detected by ELISA. Hematoxylin-eosin (HE) staining was used to detect the pathological changes of liver tissue. RESULTS:A total of 25 components and 315 corresponding targets of BLJZF were obtained, 1729 targets of lipid abnormalities and 116 common targets of BLJZF, among which the core targets were AKT1, TNF, IL1β, CASP3, etc. GO and KEGG enrichment analysis suggested that BLJZF may play a role through the lipid and atherosclerotic pathway, PI3K-Akt, AGE-RAGE in diabetic complications and other signaling pathways. Molecular docking showed that most of the core targets had high binding activity with the active ingredients. Animal experiments showed that compared with model group, TC, TG, LDL-C, ALT, AST and MDA in BLJZF group were significantly decreased, HDL-C and SOD were significantly increased, and the degree of liver fat deformation was reduced.CONCLUSION: BLJZF has a therapeutic effect on lipid abnormalities. It can treat lipid metabolism abnormalities through multi-component, multi-target and multi-pathway, and provide reference for subsequent drug research on BLJZF.
    SPP1 expression in SMARCA4-deficient non-small cell lung cancer and its relationship with PD-L1
    WU Juan, HUANG Xi, LI Jiajia, WEI Yuqing, ZHANG Liqing, YU Yongmei, LU Zhiwei, ZHANG He
    2025, 30(4):  477-486.  doi:10.12092/j.issn.1009-2501.2025.04.005
    Asbtract ( 9 )   PDF (1297KB) ( 0 )  
    Related Articles | Metrics
    AIM: To analyze the expression of secreted phosphoprotein 1 (SPP1) and programmed cell death-ligand 1 (PD-L1) in SMARCA4-deficient non-small cell lung cancer, and to provide a scientific basis for the study of the follow-up treatment of this rare pathological type of lung cancer. METHODS: The clinical and pathological characteristics of 12 patients with this disease were analyzed retrospectively, and the patients were divided into two groups of adenocarcinomas and poorly differentiated carcinomas according to their morphological characteristics, and the relationship between the expression of SPP1 and PD-L1 was analyzed in the two groups. RESULTS: SPP1 expression was detected in all patients and Its expression level was significantly higher in the poorly differentiated carcinoma group compared with the adenocarcinoma group (P=0.015); PD-L1 expression was found in 6/7 patients (5 cases were not measured), compared with the adenocarcinoma group,PD-L1 was also highly expressed in the poorly differentiated carcinoma group (P=0.048) and the PD-L1 difference between the two groups suggested that the results were similar to those of SPP1. CONCLUSION: SMARCA4-deficient non-small cell lung cancer has high positive expression of SPP1 and PD-L1. It was more pronounced in patients with poorly differentiated carcinoma. There may be a positive correlation between SPP1 and PD-L1 expression in SMARCA4-deficient non-small cell lung cancer and the mechanism of the correlation needs to be further verified in subsequent studies.
    The role of ADAM10/Notch3 signaling pathway in the proliferation of rat PASMCs and intervention of total saponins of Panax notoginseng 
    HUANG Man, BAI Xiangshu, TIAN Yunna, XU Junpeng, WANG Xiaoting, ZHANG Sai, YUAN Linbo, WANG Wantie
    2025, 30(4):  487-492.  doi:10.12092/j.issn.1009-2501.2025.04.006
    Asbtract ( 12 )   PDF (869KB) ( 0 )  
    Related Articles | Metrics
    AIM: To investigate the effect and mechanism of panax notoginseng saponins (PNS) inhibiting the proliferation of pulmonary artery smooth muscle cells (PASMCs) in rats under the effect of monocrotaline (MCT). METHODS: PASMCs cultured in vitro were randomly divided into the normal control (Control) group, the monocrotaline (MCT) group, the panax notoginseng saponins (PNS) group, the knockdown (M+Si ADAM10) group, the knockdown postconditioning (M+P+Si ADAM10) group, the overexpression (M+OE ADAM10) group, and the overexpression postconditioning (M+P+OE ADAM10) group. After the model was constructed, the cell viability of each group was measured using the CCK-8 assay, along with Western blot utilized to detect the expression of proliferating cell nuclear antigen (PCNA), disintegrin metalloproteinase 10 (ADAM10), and notch homology protein-3 (Notch3) at the cellular neurogenic locus, respectively. RESULTS:Under the effect of MCT, the viability of PASMCs was significantly enhanced (P<0.05 or P<0.01); 0-400 mg/L PNS was not toxic to the viability of normal cells, and 100 mg/L PNS could significantly inhibit the MCT-induced viability (P<0.01). After the knockdown of ADAM10, the viability of PASMCs significantly declined (P<0.01),and the expression of PCNA protein was significantly decreased (P<0.05), evidently in the M+P+Si ADAM10 group. Meanwhile, the expression of ADAM10 and Notch3 protein was significantly decreased (P<0.05 or P<0.01), evidently in the M+P+Si ADAM10 group. After overexpression of ADAM10, the viability of PASMCs was significantly enhanced (P<0.01), the expression of PCNA protein was significantly increased (P<0.01), the PCNA value was slightly higher (P>0.05), and the expression of ADAM10 and Notch3 protein was significantly elevated (P<0.05) in the M+P+OE ADAM10 group. Additionally, PASMCs overexpressing ADAM10 with concomitant PNS exhibited a significant decrease in the expression of PCNA protein compared with PASMCs knocking down ADAM10 (P<0.01), and the expression of ADAM10 and Notch3 protein declined to varying degrees (P>0.05).CONCLUSION: Panax notoginseng saponins can mitigate MCT-induced PASMCs proliferation in rats by inhibiting the ADAM10/Notch3 signaling pathway.
    Optimizing the dosing regimen of aripiprazole microspheres by population pharmacokinetic modeling and simulation
    MENG Qingheng, HAN Zhihui, LEI Qi, CHEN Bin, YIN Xia, HU Haitang, LIU Hongxia, ZHENG Qingshan, XU Ling, HUANG Qin
    2025, 30(4):  493-500.  doi:10.12092/j.issn.1009-2501.2025.04.007
    Asbtract ( 9 )   PDF (2366KB) ( 0 )  
    Related Articles | Metrics
    AIM: To optimize the clinical dosage and administration regimen of a novel long-acting injectable aripiprazole microsphere (LZMT05) using plasma concentration data from two clinical trials. METHODS: Plasma concentrations were collected from 196 schizophrenia patients administered LZMT05, and a population pharmacokinetic (PopPK) model was developed. The therapeutic window was defined as the steady-state trough-to-peak concentration range (94.0-534 ng/mL) of oral aripiprazole. Multiple clinical scenarios were simulated to identify the optimal regimen. RESULTS: A one-compartment model with dual first-order absorption and first-order elimination characterized LZMT05 pharmacokinetics. Covariates like sex and CYP2D6 genotype were integrated into the final model. Simulations demonstrated that switching from 10 mg oral aripiprazole to 350 mg LZMT05 every 4 weeks sustained concentrations within the therapeutic window with minimal peak-to-trough fluctuations. CONCLUSION: The PopPK-guided optimized LZMT05 regimen maintained drug exposure within the therapeutic window, suggesting favorable efficacy and safety.
    The relationship between NLRC4-mediated inflammasome pathway and multiple myeloma and its therapeutic prospect
    XU Tingting, WANG Wanjie, BAO Jing, XIA Ruixiang
    2025, 30(4):  501-508.  doi:10.12092/j.issn.1009-2501.2025.04.008
    Asbtract ( 10 )   PDF (1118KB) ( 0 )  
    Related Articles | Metrics
    AIM: To explore the mechanism of action and clinical significance of NLRC4 in multiple myeloma by analyzing the relative expression and clinical significance of NLRC4 mRNA in bone marrow fluid of patients with multiple myeloma (MM), so as to guide the formulation of disease treatment and the evaluation of clinical prognosis. METHODS: MMRF database and GTEx database were used to compare the expression and survival correlation of inflammatory bodies between myeloma patients and normal controls. Real-time fluorescent quantitative polymerase chain reaction (qPCR) was used to detect the expression of inflammatory bodies in bone marrow fluid of 26 newly diagnosed myeloma patients and 19 post-treatment myeloma patients and peripheral blood of 28 normal volunteers admitted to the First Affiliated Hospital of Anhui Medical University from January to September 2023. The mRNA expression differences of each inflammatory body and the correlation between NLRC4 inflammatory body expression and clinicopathologic features, inflammatory factor/chemokine expression of newly diagnosed patients were analyzed. RESULTS: Compared with the control group and the treatment group, the expression of inflammasome mRNA in the newly diagnosed group was increased except for NLRP3, and the expression of NLRC4 mRNA was significantly increased (P<0.01). The hemoglobin count, creatinine level and calcium ion level were linearly correlated with NLRC4 mRNA expression level in newly diagnosed patients (P<0.05). The mRNA expression levels of IL-18, CCL-3 and NLRC4 in newly diagnosed patients were linearly correlated (P<0.05). CONCLUSION: NLRC4 inflammatosomes are highly expressed in MM, and promote the occurrence and development of tumor by promoting the production and release of inflammatory cytokines/chemokines IL-18 and CCL-3, which is of great significance for the formulation of treatment plan and clinical prognosis evaluation of multiple myeloma.
    Exploratory study of fecal microbiota transplantation combined with immune checkpoint inhibitors in the treatment of end-stage malignant tumor patients
    CHU Yunqian, XUE Ya, JIANG Hua, QI Chunjian, DAI Hanjue, XIAN Qingying, ZHU Wenyu
    2025, 30(4):  509-516.  doi:10.12092/j.issn.1009-2501.2025.04.009
    Asbtract ( 12 )   PDF (1325KB) ( 0 )  
    Related Articles | Metrics
    AIM: To explore the efficacy and safety of fecal microbiota transplantation combined with immune checkpoint inhibitors (ICIs) for malignant tumor patients with failed multi line anti-tumor treatment and concomitant cachexia, and to explore the changes in blood immunity and intestinal microbial environment in patients. METHODS: Five patients with malignant tumors who failed multi line anti-tumor treatment were enrolled and treated with ICIs combined with fecal microbiota transplantation. The efficacy was evaluated every 2-3 cycles, and adverse reactions were observed. Fecal 16srRNA gene sequencing and serum immunological indicators were dynamically detected. RESULTS: Except for one patient who died 2.5 months after transplantation due to excessive tumor burden at enrollment, the overall survival of the remaining four patients were extended (7.4, 8.3, 28.5, 52.3 months). One patient with multiple intracranial metastases of lung adenocarcinoma significantly reduced the intracranial metastasis after intestinal microbiota transplantation and almost disappeared. The serum IL-2, IL-10, TGF-β and other indicators of patients increased rapidly and then slowly decreased with the increase of transplantation time, and finally were higher than before transplantation, with statistical differences. 16srRNA gene sequencing analysis revealed significant differences in the overall distribution of gut microbiota in patients after transplantation, gradually approaching healthy transplant donors. All patients did not experience grade 2 or above adverse reactions, and the safety was good. CONCLUSION: For patients with malignant tumors, the combination of fecal microbiota transplantation and immunotherapy may improve their quality of life, serum immune environment, and intestinal microbiota composition, have a positive impact on survival prognosis, and are safe and controllable, opening up new treatment methods for end-stage patients.
    Research progress of epigenetics in the pathogenesis of depression
    ZHANG Yao, ZOU Manshu, HAN Yuanshan, WANG Yuhong
    2025, 30(4):  517-525.  doi:10.12092/j.issn.1009-2501.2025.04.010
    Asbtract ( 12 )   PDF (924KB) ( 1 )  
    Related Articles | Metrics
    Depression is a mental disease with increasing prevalence worldwide, which seriously endangers human health with high disability rate and high suicide rate. Epigenetics is an emerging genetic theory in the 21st century. Its main research content is to regulate the process of gene transcription or translation and affect its function and characteristics without changing the DNA sequence. These include DNA methylation, histone modification, chromatin remodeling and non-coding RNA regulation. The nervous system is susceptible to changes in the activity of epigenetic modifiers, and an increasing number of studies have shown that genetics and environment play an important role in the development of depression. This review will focus on the epigenetic mechanisms of depression.
    Effects of branched-chain and aromatic amino acids on type 2 diabetes mellitus and the progress
    ZHANG Mengli, WU Fangfang, TAN Zhien, OU Min, LIU Lingjie, LU Na, QIAO Liya, YANG Xiaonan
    2025, 30(4):  526-532.  doi:10.12092/j.issn.1009-2501.2025.04.011
    Asbtract ( 11 )   PDF (1193KB) ( 0 )  
    Related Articles | Metrics
    Type 2 diabetes mellitus is a metabolic disease characterized by high blood sugar levels. Traditionally, amino acids are primarily viewed as the basic building blocks for proteins and peptide synthesis. However, in recent years, amino acids have gained increased attention as signaling molecules that play crucial roles in the maintenance and regulation of metabolic homeostasis. It has been found that there is a close correlation between the metabolism of branched-chain and/or aromatic amino acids and the occurrence or development of type 2 diabetes mellitus. Furthermore, there have been successive reports on the regulation mechanism involved. This article will focus on the metabolic processes, mechanisms and clinical value of branched-chain and aromatic amino acids in type 2 diabetes mellitus. It will also summarize and provide an outlook on the current state of amino acid metabolism in the treatment of diabetes mellitus, with the aim of offering new ideas for the treatment of type 2 diabetes mellitus.
    Recent research progress of Menin inhibitors in NPM1-mutated acute myeloid leukemia
    YU Xiaoda, LI Jiajing, WANG Anan, GUO Jiangang, LIU Bei
    2025, 30(4):  533-540.  doi:10.12092/j.issn.1009-2501.2025.04.012
    Asbtract ( 7 )   PDF (999KB) ( 0 )  
    Related Articles | Metrics
    The nucleophosmin 1 (NPM1) mutation is one of the most frequent subtypes in acute myeloid leukemia (AML). Under the conditions of FLT3-internal tandem duplications (FLT3-ITD) and/or DNMT3A co-mutations or adverse cytogenetics, the originally favorable prognosis will deteriorate. In recent years, studies have found that multiple endocrine neoplasia protein (Menin) inhibitors targeting Menin-KMT2A complex can downregulate the overexpression of leukemia causing genes HOX (homeotic gene) and MEIS1 (myeloid ecotropic viral integration site 1) in NPM1-mutated AML, demonstrating remarkable anti-leukemia activity. This article aims to review the mechanism and clinical research of Menin inhibitors, novel small molecule targeted drugs in NPM1-mutated AML, as well as the resistance mechanism of Menin inhibitors, hoping to provide promising approaches for the subsequent treatment of NPM1-mutated AML patients. 
    Role of mitochondrial homeostasis in the pathogenesis of rheumatoid arthritis
    JIA Dongye, PAN Zhi
    2025, 30(4):  541-547.  doi:10.12092/j.issn.1009-2501.2025.04.013
    Asbtract ( 10 )   PDF (982KB) ( 0 )  
    Related Articles | Metrics
    Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that can affect joints and extra-articular organs, including the heart, kidneys, lungs, digestive system, eyes, skin, and nervous system. During RA, mitochondrial homeostasis is altered, leading to the production of inflammatory mediators and joint damage by affecting cartilage and synovial tissues. Regulating mitochondrial homeostasis is a key step in slowing the progression of RA. This study conducts a comprehensive literature review on the topics of "rheumatoid arthritis" and "mitochondrial homeostasis" over the past decade. It aims to summarize and analyze the factors contributing to mitochondrial homeostasis imbalance in RA, as well as the potential role of modulating mitochondrial homeostasis in ameliorating RA, with the ultimate goal of offering novel insights and approaches for RA treatment.
    Research progress on the role of macrophage polarization in cardiovascular diseases
    CUI Hanyu, HU Changping
    2025, 30(4):  548-555.  doi:10.12092/j.issn.1009-2501.2025.04.014
    Asbtract ( 8 )   PDF (699KB) ( 0 )  
    Related Articles | Metrics
    As phagocytic innate immune cells, macrophages interact with various tissue types and play an important role in immune defense, inflammatory response and tissue remodeling. Macrophages participate in the occurrence and development of disease by polarizing into classically activated M1 type and substitutively activated M2 type, or more complex phenotypes, when the tissue microenvironment changes. This paper focused on the application of macrophage polarization in cardiovascular diseases, and introduces macrophage origin and activation to propose the relationship between macrophage polarization and cardiovascular diseases. Then, the strategies for targeted macrophage therapy were proposed to provide an important theoretical basis for improving the inflammatory state of cardiovascular diseases.
    Research progress of traditional Chinese medicine intervention in chemotherapy renal injury
    LIU Yeyuan, QI Yafeng, ZHANG Maofu, LI Xinyu, SHEN Yanyun, LIU Yu, ZHANG Shangzu, LI Yangyang, ZHANG Liying, ZHANG Zhiming
    2025, 30(4):  556-569.  doi:10.12092/j.issn.1009-2501.2025.04.015
    Asbtract ( 10 )   PDF (843KB) ( 0 )  
    Related Articles | Metrics
    Renal injury is one of the common adverse reactions in the clinical application of chemotherapy drugs, which is the main reason why the chemotherapy can not be carried out in the whole cycle. The pathological mechanism of chemotherapy-induced renal injury is very complicated, mainly involving oxidative stress, inflammatory response, apoptosis, mitochondrial dysfunction, and regulation of transporters, causing pathological damage to renal tubules or glomeruli. At present, there is no specific pharmacological intervention for the treatment of chemotherapy-induced renal injury. As a treasure of traditional Chinese medicine, traditional Chinese medicine has the advantages of overall regulation, multi-targeting, small adverse reactions and no obvious drug dependence in the prevention and treatment of chemotherapy-induced renal injury. In recent years, there have been more and more studies on the intervention of chemotherapy-induced renal injury by multi-component and multi-directional intervention of active components, extracts and compounds of traditional Chinese medicine, and some progress has been made. A large number of studies have shown that the potential mechanisms of traditional Chinese medicine in preventing and treating renal injury induced by chemotherapy include inhibiting oxidative stress, reducing inflammatory response and inhibiting apoptosis. Although there are many studies on the mechanism of action of traditional Chinese medicine in the treatment of chemotherapy-induced renal injury, there is still a lack of systematic review. Based on this, this paper summarizes the mechanism of renal injury induced by chemotherapy and the intervention of traditional Chinese medicine, so as to provide theoretical support for its clinical treatment and new drug innovation.
    Research progress on pharmacokinetic interactions of sodium-glucose co-transporter 2 inhibitors
    DENG Yanru, CAO Gexi, LI Ying, LI Yajing, DONG Zhanjun
    2025, 30(4):  570-576.  doi:10.12092/j.issn.1009-2501.2025.04.016
    Asbtract ( 10 )   PDF (651KB) ( 1 )  
    Related Articles | Metrics
    Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a new class of oral hypoglycemic drugs with definite hypoglycemic effects, low risk of hypoglycemia, cardiovascular protection, and kidney benefits. In recent years, SGLT2 inhibitors have been widely used in clinical practice, and their interactions with other drugs have gradually attracted attention. The SGLT2 inhibitors commonly used in China's clinic include canagliflozin, dapagliflozin, empagliflozin, ertugliflozin and henagliflozin currently, they are mainly metabolized by the phase Ⅱ metabolic enzyme uridine diphosphate glucuronosyltransferase (UGT), and various transporters are involved in the disposal of SGLT2 inhibitors in vivo. This article reviews the pharmacokinetic characteristics of different SGLT2 inhibitors mentioned above, as well as their pharmacokinetic interaction studies with various drugs such as statins, antineoplastic drugs, antimicrobials, nonsteroidal anti-inflammatory drugs and traditional Chinese medicine, in order to promote the safe and rational use of SGLT2 inhibitors in clinical practice.